TEMPEST THERAPEUTICS INC (TPST) Stock Balance Sheet
NASDAQ:TPST • US87978U2078
Current stock price
1.96 USD
-0.28 (-12.5%)
At close:
1.98 USD
+0.02 (+1.02%)
After Hours:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 7.51M | 30.27M | 39.23M | 31.20M | 51.80M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 590.00K | 1.21M | 1.13M | 1.70M | 17.20M | |||
| Total Current Assets | 8.10M | 31.47M | 40.36M | 33.00M | 69.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.51M | 9.53M | 10.79M | 12.70M | 4.20M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 519.00K | 485.00K | 448.00K | 400.00K | 100.00K | |||
| Total Non-Current Assets | 9.03M | 10.01M | 11.24M | 13.10M | 4.20M | |||
| TOTAL ASSETS | 17.13M | 41.49M | 51.60M | 46.10M | 73.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 0.00 | 6.35M | 4.29M | N/A | N/A | |||
| Accrued Expenses | 2.60M | 5.42M | 4.28M | 5.70M | 4.00M | |||
| Accounts Payable | 922.00K | 2.45M | 845.00K | 1.10M | 1.00M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 500.00K | 15.00M | |||
| Total Current Liabilities | 3.52M | 14.22M | 9.41M | 7.30M | 20.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 6.26M | 10.40M | 15.10M | |||
| Other Non-Current Liabilities | 7.26M | 8.14M | 9.16M | 10.30M | 2.00M | |||
| Total Non-Current Liabilities | 7.26M | 8.14M | 15.42M | 20.70M | 17.10M | |||
| TOTAL LIABILITIES | 10.78M | 22.36M | 24.84M | 28.00M | 37.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -229.35M | -207.11M | -165.26M | -135.80M | -100.10M | |||
| Additional Paid In Capital | 235.69M | 226.19M | 192.01M | 153.90M | 136.20M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 4.00K | 44.00K | 22.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 4.44M | 3.38M | 1.70M | 809.10K | 531.50K | |||
| Tangible Book Value per Share | 1.43 | 5.65 | 15.79 | 1.72 | 5.23 | |||
| Total Shareholders' Equity | 6.35M | 19.13M | 26.77M | 18.10M | 36.10M | |||
| TOTAL LIABILITIES AND EQUITY | 17.13M | 41.49M | 51.60M | 46.10M | 73.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.23 | 0.57 | 0.42 | |||
| Current Ratio | 2.30 | 2.21 | 4.29 | 4.52 | 3.45 | |||
| Return On Assets (ROA) | -210.49% | -100.86% | -57.15% | -77.46% | -38.66% | |||
| Return On Equity (ROE) | -568.14% | -218.78% | -110.17% | -197.29% | -78.39% | |||
All data in USD , ROIC based on taxRate of 0.21